We are monitoring the impact of COVID-19 on North America HPV Testing And Pap Test Market Get in touch with us for detailed analysis Know More
Share on

North America HPV Testing and Pap Test Market Research Report – Segmented By Application, Test Type, End User and Country (the United States, Canada and Rest of North America) - Industry Size, Share, Trends and Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3622
Pages: 145

North America HPV Testing and Pap Test Market Size (2022 to 2027)

The HPV Testing and Pap Test Market size in North America was around USD 2.10 billion in 2022. It is expected to grow at a CAGR of 6.9% to reach USD 2.92 billion by 2027. It captures 50% of the global market. It is also the fastest-growing market worldwide.

According to the WHO, cervical cancer is the fourth most common cancer in women. An estimated 6,28,924 new cases of the cervix were diagnosed in 2020, so the growing number of patients will drive overall market growth. The Centers for Disease Control (CDC) predicts that approximately 78 million people are currently infected with HPV in the United States, and it is about 14 million people in the United States are infected with new HPV infections each year. Therefore, the increasing number of cervical cancer cases has driven the market demand for HPV and Pap tests.

These tests include the microscopic observation of the samples. However, these tests cannot detect all of the genotypes that cause HPV infections and can also lead to a significant number of false negatives.

This research report on the North America HPV Testing and Pap Test Market has been segmented and sub-segmented into the following categories:

  • By Test Type: HPV Testing, Follow-up HPV Testing, HPV Primary Testing, Co-Testing and PAP Test
  • By Application: Vaginal Cancer Screening and Cervical Cancer Screening
  • By End-users: Laboratories, Hospitals, Physicians, Offices and Clinics
  • By Country: The United States, Canada, and Rest of North America

Regionally, in 2019, North America commanded the market in terms of revenue because of the continual introduction of innovative technologies to improve patient care and diagnosis. Additionally, the high number of positive cases being detected, coupled with the increasing death toll (i.e., 2.6 in 1,00,000), has forced the government to carry out awareness programs regarding the early diagnosis and treatment of cervical cancer, which is a significant factor for the large market share.

About 2.4 million people dollars should be added jobs in the industry during this period in the United States. The highest median annual salary was recorded at USD 214,000 or more for physicians and surgeons in 2020. Similarly, the median yearly salary recorded for other health professions in June 2019 was USD 172,380 for dentists, USD 149,370 for physicians, USD 97,147 for occupational therapists, and USD 31,413 for various health care support professions, such as home health aides and medical transcriptionists. According to statistics released by the United States Bureau of Labor Statistics, the employment rate of various health professionals in the health sector is expected to increase by 15% between 2020 and 2025. Increased demand for services and facilities Medical Healthcare in North America region is estimated to significantly impact the North American Pap test and HPV test market growth in the area between 2020 and 2025. 

Besides, the increase in spending on the population of countries like the United States and Canada further stimulates this industry's growth. Per capita purchasing power parity (PPP) -based health expenditure in the United States has increased significantly from $ 9,272.27 in 2018 to $ 10,235.18 in 2020, while it increased from USD 4,832.83 USD in 2018 to USD 5,151 in 2020 in Canada. According to the World Health Organization, spending on personal health care in the United States, reported by the Centers for Disease Control and Prevention, is expected to increase by a 4.8% annual percentage change in percentage over the period 2010-2020, with spending a total of $ 2.237 billion in 2010, which rose to 3.231 billion USD in 2020. It can be attributed to the high demand for new drugs.

Some of the companies dominating the North America HPV Testing and PAP Test Market profiled in this report are Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Becton, Dickinson and Company, Quest Diagnostics, Onco Health Corporation, Seegene, Inc., Femasys Inc., and Arbor Vita Corporation.

1.Introduction                                                                                  

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 Epidemology                                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Type                                                                              

                                5.1.1 Introduction                                                           

                                5.1.2 HPV Testing                                                            

                                5.1.3 Follow-Up HPV Testing                                                      

                                5.1.4 Co-Testing                                                               

                                5.1.5 Primary HPV Testing                                                           

                                5.1.6 PAP Test                                                  

                                5.1.7  Y-o-Y Growth Analysis, By Type                                                    

                                5.1.8  Market Attractiveness Analysis, By Type                                                  

                                5.1.9  Market Share Analysis, By Type                                                    

                5.2 Application                                                                 

                                5.2.1 Introduction                                                           

                                5.2.2 Cervical Cancer Screening                                                 

                                5.2.3 Vaginal Cancer Screening                                                  

                                5.2.4 Y-o-Y Growth Analysis, By Application                                                         

                                5.2.5 Market Attractiveness Analysis, By Application                                                       

                                5.2.6 Market Share Analysis, By Application                                                        

                5.3 End User                                                                      

                                5.3.1 Introduction                                                           

                                5.3.2 Laboratories                                                           

                                5.3.3 Hospitals                                                  

                                5.3.4 Physicians’ Offices and Clinics                                                         

                                5.3.5 Y-o-Y Growth Analysis, By End User                                                             

                                5.3.6  Market Attractiveness Analysis, By End User                                                          

                                5.3.7  Market Share Analysis, By End User                                                            

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Type                                 

                                                6.1.3.3 By Application                                    

                                                6.1.3.4 By End User                                        

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Type                                 

                                                6.1.4.3 By Application                                    

                                                6.1.4.4 By End User                                        

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Type                                 

                                                6.1.5.3 By Application                                    

                                                6.1.5.4 By End User                                        

                6.2 United States                                                                            

                6.3 Canada                                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Qiagen N.V.                                                                

                8.3 Roche Diagnostics                                                                    

                8.4 Hologic, Inc.                                                                

                8.5 Becton, Dickinson and Company                                                                       

                8.6 Quest Diagnostics                                                                    

                8.7 Onco Health Corporation                                                                      

                8.8 Seegene, Inc.                                                                            

                8.9 Femasys Inc.                                                                              

                8.10 Arbor Vita Corporation                                                                        

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Market Outlook and Investment Opportunities                                                                                         

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

 

  1. North America HPV testing and Pap Test Market, By Type, From 2022 - 2027 (USD Million)
  2. North America HPV Testing Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Follow-up HPV Testing Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Co-testing Market, By Region, From 2022 - 2027 (USD Million)
  5. North America HPV Primary testing Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Pap Test Market, By Region, From 2022 - 2027 (USD Million)
  7. North America HPV testing and Pap Test Market, By Application, From 2022 - 2027 (USD Million)
  8. North America Pap Test Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Cervical Cancer Screening Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Vaginal Cancer Screening Market, By Region, From 2022 - 2027 (USD Million)
  11. North America HPV testing and Pap Test Market, By End User, From 2022 - 2027 (USD Million)
  12. North America Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Physician’s Offices & Clinics Market, By Region, From 2022 - 2027 (USD Million)
  15. United States HPV testing and Pap Test Market, By Type, From 2022 - 2027 (USD Million)
  16. United States HPV testing and Pap Test Market, By Application, From 2022 - 2027 (USD Million)
  17. United States HPV testing and Pap Test Market, By End User, From 2022 - 2027 (USD Million)
  18. Canada HPV testing and Pap Test Market, By Type, From 2022 - 2027 (USD Million)
  19. Canada HPV testing and Pap Test Market, By Application, From 2022 - 2027 (USD Million)
  20. Canada HPV testing and Pap Test Market, By End User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample